COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 344: Articles 3431-3440  | Next

Revealing and evaluation of antivirals targeting multiple druggable sites of RdRp complex in SARS-CoV-2
Rani, R., Nehul, S., Choudhary, S., Upadhyay, A., Sharma, G. K., Kumar, P., Tomar, S.
10.1101/2023.07.24.550324 — Posted: 2023-07-24
Endothelial SARS-CoV-2 infection is not the underlying cause of COVID19-associated vascular pathology in mice
Gao, S., Tang, A. T., Wang, M., Buchholz, D. W., Imbiakha, B., Yang, J., Chen, X., Hewins, P., Mericko-Ishizuka, P., Leu, N. A., Sterling, S., August, A., Jurado, K., Morrisey, E., Aguilar-Carreno, H., Kahn, M. L.
10.1101/2023.07.24.550352 — Posted: 2023-07-24
Biophysical principles predict fitness of SARS-CoV-2 variants
Wang, D., Huot, M., Mohanty, V., Shakhnovich, E. I.
10.1101/2023.07.23.549087 — Posted: 2023-07-24
AmpliDiff: An Optimized Amplicon Sequencing Approach to Estimating Lineage Abundances in Viral Metagenomes
van Bemmelen, J., Smyth, D. S., Baaijens, J. A.
10.1101/2023.07.22.550164 — Posted: 2023-07-24
Genomic epidemiology of European Aspergillus fumigatus causing COVID-19-associated pulmonary aspergillosis in Europe
Simmons, B., Rhodes, J., Rogers, T., Talento, A. F., Griffin, A., Mansfield, M., Abdolrasouli, A., Verweij, P. E., Bosch, T., Schelenz, S., Hemmings, S., Sheehan, D., Fisher, M. C.
10.1101/2023.07.21.550109 — Posted: 2023-07-24
Phylogeny and evolution of the SARS-CoV-2 spike gene from December 2022 to February 2023
Kao, H.-W., Kao, H.-W.
10.1101/2023.07.23.549423 — Posted: 2023-07-24
Comparison of the analytical and clinical sensitivity of thirty-four rapid antigen tests with the most prevalent SARS-CoV-2 variants of concern during the COVID-19 pandemic in the UK
Byrne, R. L., Aljayyoussi, G., Greenland - Bews, C., Kontogianni, K., Wooding, D., Williams, C. T., de Vos, M., Body, R., Adams, E. R., Escadafel, C., Edwards, T. R., Cubas Atienzar, A. I.
10.1101/2023.07.24.23293072 — Posted: 2023-07-24
Incubation-period estimates of Omicron (BA.1) variant from Taiwan, December 2021-January 2022, and its comparison to other SARS-CoV-2 variants: a statistical modeling, systematic search and meta-analysis
Akhmetzhanov, A. R., Cheng, H.-Y., Dushoff, J.
10.1101/2023.07.20.23292983 — Posted: 2023-07-24
Temporal changes in the positivity rate of common enteric viruses among paediatric admissions in coastal Kenya, in the period spanning the COVID-19 pandemic, 2019-2022
LAMBISIA, A. W., Murunga, N., Mutunga, M., Cheruiyot, R., Maina, G., MAKORI, T. O., Nokes, D. J., Agoti, C. N.
10.1101/2023.07.24.23293059 — Posted: 2023-07-24
Impact of Emerging COVID-19 variants on psychosocial health: A Systematic Review
Kumar, P., Sarkar, M., Yurkina, M. F., Gnanaraj, R., Martinez, D. J. G., Pisfil-Farronay, Y. A., Chaudhary, L., Agrawal, P., Kaushal, G. P., Mbwogge, M., Abhishek, K., Alnaasan, M., Arlettaz, M. E., Kozum, R., Moyron, M. F. J., Panchawagh, S., Reddy, A. P., Unnithan, V. B.
10.1101/2023.07.23.23293040 — Posted: 2023-07-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).